- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00005341
Blood Donation--Immune Sequelae and Recruitment
Study Overview
Status
Conditions
Detailed Description
DESIGN NARRATIVE:
The study had two objectives. The first objective was to investigate changes in immune function which may have occurred as a result of blood, plasma, or platelet donations. Preliminary studies had shown evidence of alterations in immune parameters in normal apheresis donors with the most marked changes occurring in long-term plasmapheresis donors. To ascertain whether donation of blood or blood products altered specific immune parameters, studies were conducted on white blood cell (WBC) receptors known to be involved in normal host defense mechanisms, lymphocyte subpopulations, plasma proteins, and complement activation products from 30 individuals in each of four separate donor groups: whole blood donors, bulk plasma donors, plasma donors stimulated with incompatible RBC, and platelet donors. Donor immune data were compared with results in nondonor controls and were also correlated with demographic data, donation history, laboratory data, and clinical findings. The second objective of the study was to determine if changes in an individual donor's immune status occurred over time. A longitudinal study of 15 new donors in each donation group was performed to evaluate alterations in immune function that may have occurred in committed donors of blood products and whether there was any clinical significance to the findings. New donors were enrolled in donation groups and followed longitudinally for a period of up to two years.
The study was extended through January, 1997 on FY 1995 funds.
Study Type
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Study Plan
How is the study designed?
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4204
- R01HL045642 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Disease
-
Assistance Publique Hopitaux De MarseilleNot yet recruitingBlood Platelet Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Lung Diseases | Blood Disease
-
University of UlsterCompletedBlood PressureUnited Kingdom
-
Azienda Ospedaliera San Giovanni BattistaUnknown
-
Hamad Medical CorporationSidra Medical and Research Center; World Anti-Doping Agency; Anti-Doping Lab... and other collaboratorsUnknownBlood Disease | Blood Transfusion, Autologous | Blood Doping | Blood Transfusion, HomologousQatar
-
University of Wisconsin, MadisonUniversity of Wisconsin Carbone Cancer Center (UWCCC)Not yet recruiting
-
Archemix Corp.Withdrawn
-
Uniform Data System for Medical RehabilitationTerminatedNervous System Diseases | Wounds and Injuries | Heart and Blood Disease | Muscle, Bone and Cartilage Disease | Skin and Connective Tissue DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedAnemia | Blood Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Coronary Disease | Lung Diseases | Hypertension | Blood Disease